BNP Paribas Financial Markets’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.34M | Sell |
19,200
-102,339
| -84% | -$7.49M | ﹤0.01% | 3114 |
|
|
2026
Q1 | $8.74M | Sell |
121,539
-88,759
| -42% | -$5.05M | ﹤0.01% | 1644 |
|
|
2025
Q4 | $8.89M | Buy |
210,298
+209,864
| +48,356% | +$11.7M | ﹤0.01% | 1689 |
|
|
2025
Q3 | $24.7K | Buy |
434
+210
| +94% | +$6.95K | ﹤0.01% | 4858 |
|
|
2025
Q2 | $5.79K | Sell |
224
-19,248
| -99% | -$216K | ﹤0.01% | 4942 |
|
|
2025
Q1 | $199K | Sell |
19,472
-1,374
| -7% | -$18K | ﹤0.01% | 3703 |
|
|
2024
Q4 | $291K | Buy |
20,846
+4,923
| +31% | +$86.8K | ﹤0.01% | 3658 |
|
|
2024
Q3 | $311K | Buy |
15,923
+15,118
| +1,878% | +$288K | ﹤0.01% | 3059 |
|
|
2024
Q2 | $15K | Buy |
805
+627
| +352% | +$13.2K | ﹤0.01% | 3679 |
|
|
2024
Q1 | $2.49K | Sell |
178
-16,046
| -99% | -$168K | ﹤0.01% | 3795 |
|
|
2023
Q4 | $137K | Sell |
16,224
-173
| -1% | -$1.31K | ﹤0.01% | 3325 |
|
|
2023
Q3 | $146K | Buy |
16,397
+5,560
| +51% | +$53.5K | ﹤0.01% | 3216 |
|
|
2023
Q2 | $93.5K | Buy |
10,837
+1,144
| +12% | +$12.2K | ﹤0.01% | 3276 |
|
|
2023
Q1 | $102K | Buy |
9,693
+5,786
| +148% | +$175K | ﹤0.01% | 3325 |
|
|
2022
Q4 | $132K | Sell |
3,907
-2,822
| -42% | -$137K | ﹤0.01% | 3144 |
|
|
2022
Q3 | $323K | Sell |
6,729
-14,231
| -68% | -$847K | ﹤0.01% | 3255 |
|
|
2022
Q2 | $1.19M | Buy |
20,960
+4,904
| +31% | +$309K | ﹤0.01% | 2092 |
|
|
2022
Q1 | $1.3M | Buy |
16,056
+7,539
| +89% | +$1.12M | ﹤0.01% | 2135 |
|
|
2021
Q4 | $1.73M | Buy |
8,517
+3,617
| +74% | +$785K | ﹤0.01% | 2168 |
|
|
2021
Q3 | $1.32M | Buy |
4,900
+319
| +7% | +$76.7K | ﹤0.01% | 2187 |
|
|
2021
Q2 | $1.18M | Sell |
4,581
-145
| -3% | -$40.1K | ﹤0.01% | 2081 |
|
|
2021
Q1 | $1.42M | Buy |
4,726
+226
| +5% | +$70.3K | ﹤0.01% | 1910 |
|
|
2020
Q4 | $1.15M | Buy |
4,500
+1,043
| +30% | +$270K | ﹤0.01% | 1935 |
|
|
2020
Q3 | $860K | Sell |
3,457
-133
| -4% | -$41.8K | ﹤0.01% | 1892 |
|
|
2020
Q2 | $1.25M | Sell |
3,590
-13,095
| -78% | -$4.09M | ﹤0.01% | 1696 |
|
|
2020
Q1 | $4.47M | Sell |
16,685
-4,540
| -21% | -$1.4M | 0.01% | 1033 |
|
|
2019
Q4 | $6.87M | Buy |
21,225
+14,245
| +204% | +$4.13M | 0.01% | 1031 |
|
|
2019
Q3 | $1.91M | Buy |
6,980
+1,949
| +39% | +$715K | ﹤0.01% | 1536 |
|
|
2019
Q2 | $2.69M | Sell |
5,031
-235
| -4% | -$118K | 0.01% | 1321 |
|
|
2019
Q1 | $2.65M | Buy |
5,266
+1,368
| +35% | +$811K | 0.01% | 1279 |
|
|
2018
Q4 | $1.92M | Sell |
3,898
-3,736
| -49% | -$2.26M | ﹤0.01% | 1325 |
|
|
2018
Q3 | $6.98M | Sell |
7,634
-5,220
| -41% | -$4.46M | 0.01% | 989 |
|
|
2018
Q2 | $9.41M | Buy |
12,854
+9,016
| +235% | +$10.4M | 0.02% | 823 |
|
|
2018
Q1 | $6.12M | Sell |
3,838
-2,316
| -38% | -$2.98M | 0.01% | 905 |
|
|
2017
Q4 | $5.51M | Sell |
6,154
-1,352
| -18% | -$800K | 0.01% | 997 |
|
|
2017
Q3 | $2.7M | Buy |
7,506
+2,066
| +38% | +$646K | 0.01% | 1005 |
|
|
2017
Q2 | $1.6M | Buy |
5,440
+294
| +6% | +$85K | ﹤0.01% | 1306 |
|
|
2017
Q1 | $1.81M | Buy |
5,146
+569
| +12% | +$128K | ﹤0.01% | 1101 |
|
|
2016
Q4 | $842K | Buy |
4,577
+641
| +16% | +$130K | ﹤0.01% | 1425 |
|
|
2016
Q3 | $1.01M | Sell |
3,936
-1,461
| -27% | -$376K | ﹤0.01% | 921 |
|
|
2016
Q2 | $1.15M | Buy |
5,397
+1,306
| +32% | +$292K | 0.01% | 1115 |
|
|
2016
Q1 | $844K | Sell |
4,091
-5,522
| -57% | -$1.06M | ﹤0.01% | 1070 |
|
|
2015
Q4 | $2.43M | Buy |
9,613
+3,331
| +53% | +$685K | 0.01% | 862 |
|
|
2015
Q3 | $1.03M | Buy |
6,282
+1,227
| +24% | +$217K | ﹤0.01% | 1039 |
|
|
2015
Q2 | $949K | Buy |
5,055
+4,690
| +1,285% | +$807K | ﹤0.01% | 1139 |
|
|
2015
Q1 | $60.1K | Buy |
365
+219
| +150% | +$45K | ﹤0.01% | 1869 |
|
|
2014
Q4 | $33.9K | Sell |
146
-380
| -72% | -$81.2K | ﹤0.01% | 1731 |
|
|
2014
Q3 | $95.2K | Buy |
526
+517
| +5,744% | +$98.9K | ﹤0.01% | 2214 |
|
|
2014
Q2 | $1.81K | Sell |
9
-2
| -18% | -$354 | ﹤0.01% | 3163 |
|
|
2014
Q1 | $1.86K | Sell |
11
-89
| -89% | -$17.6K | ﹤0.01% | 2683 |
|
|
2013
Q4 | $17K | Sell |
100
-2,021
| -95% | -$326K | ﹤0.01% | 2317 |
|
|
2013
Q3 | $332K | Sell |
2,121
-566
| -21% | -$105K | ﹤0.01% | 1843 |
|
|
2013
Q2 | $466K | Buy |
+2,687
| New | +$412K | ﹤0.01% | 1614 |
|
Other funds holding NKTR
TSC
AC
GGHC
B
BNP Paribas Financial Markets's NKTR Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Nektar Therapeutics (NKTR) stake by 84% in Q2 2026, selling an estimated $7.49M and leaving 19,200 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3114.
BNP Paribas Financial Markets first reported a position in NKTR in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.41M in Q2 2018. 219 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.
- BNP Paribas Financial Markets held 19,200 shares of Nektar Therapeutics worth $1.34M as of Q2 2026.
- BNP Paribas Financial Markets sold 102,339 Nektar Therapeutics shares in Q2 2026, an estimated $7.49M.
- Nektar Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3114 holding.
- BNP Paribas Financial Markets first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's Nektar Therapeutics position peaked at $9.41M in Q2 2018.
- 219 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.